相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacogenetics of antipsychotics: Clinical utility and implementation
Maria J. Arranz et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Prescription Pattern of Antidepressants and the Potential for Personalized Medicine in the Qatari Population
Kholoud Bastaki et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database
Carlo Piccinni et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Patterns of prescription of antipsychotics in Qatar
Sami Ouanes et al.
PLOS ONE (2020)
Prescribing in borderline personality disorder - the clinical guidelines
Devender Yadav
PROGRESS IN NEUROLOGY AND PSYCHIATRY (2020)
Association Between Antipsychotics and All-Cause Mortality Among Community-Dwelling Older Adults
Raya Elfadel Kheirbek et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
Abel Thamby et al.
INDIAN JOURNAL OF PSYCHIATRY (2019)
A Systematic Review of Atypical Antipsychotics in Chronic Pain Management Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine
Xavier F. Jimenez et al.
CLINICAL JOURNAL OF PAIN (2018)
Management of common adverse effects of antipsychotic medications
T. Scott Stroup et al.
WORLD PSYCHIATRY (2018)
From genomes to genomic medicine: enabling personalized and precision medicine in the Middle East
Puthen Veettil Jithesh et al.
PERSONALIZED MEDICINE (2017)
Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
Sulaiman Alkhadhari et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis
David Veale et al.
BMC PSYCHIATRY (2014)
Prescribing of antipsychotics in UK primary care: a cohort study
Louise Marston et al.
BMJ OPEN (2014)
Atypical antipsychotics as a possible treatment option for irritable bowel syndrome
Chi-Un Pae et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Prescribing of Psychotropic Medications to Patients Without a Psychiatric Diagnosis
Ilse R. Wiechers et al.
PSYCHIATRIC SERVICES (2013)
Off-Label Use of Atypical Antipsychotics Cause for Concern?
Andrew McKean et al.
CNS DRUGS (2012)
Psychopharmacological Treatment and Psychological Interventions in Irritable Bowel Syndrome
Emanuele Sinagra et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults A Systematic Review and Meta-analysis
Alicia Ruelaz Maher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Increasing off-label use of antipsychotic medications in the United States, 1995-2008
G. C. Alexander et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
Bernhard Baune
Neuropsychiatric Disease and Treatment (2011)
Off-label use of antipsychotics: are we mad?
Camilla Haw et al.
EXPERT OPINION ON DRUG SAFETY (2007)
分享论文
